Free Trial

Dogwood Therapeutics (DWTX) SEC Filings & 10K Form

Dogwood Therapeutics logo
$4.83 +0.07 (+1.47%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$4.78 -0.05 (-1.14%)
As of 07/18/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Dogwood Therapeutics SEC Filings

DateFilerForm TypeView
07/01/2025
12:52 PM
De La Rosa Abel (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:56 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Walsh Angela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:58 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Keefer David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:00 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Duncan Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:02 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Thomas John C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:05 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Grosswald Ralph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:07 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Whitley Richard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:11 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Gendreau Roger Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:01 PM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/24/2025
9:15 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
10:57 AM
De La Rosa Abel (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
10:59 AM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Thomas John C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
11:02 AM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Keefer David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
11:04 AM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Whitley Richard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
11:15 PM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form EFFECT
05/23/2025
4:25 PM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/09/2025
10:28 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
8:20 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
1:08 PM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form ARS
04/30/2025
7:00 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form DEF 14A
04/03/2025
8:10 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:44 PM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
7:19 PM
Conjoint Inc. (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/17/2025
8:11 PM
Dogwood Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Sealbond Ltd (Filed by)
Form SCHEDULE 13D/A
03/17/2025
8:07 PM
CK Life Sciences Intl Inc (0001297567) (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:53 PM
Dogwood Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Orca Capital AG (Filed by)
Form SCHEDULE 13G/A
03/17/2025
4:49 PM
Dogwood Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Orca Capital AG (Filed by)
Form SCHEDULE 13G
03/14/2025
10:47 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
9:32 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 424B5
03/12/2025
8:00 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
8:30 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K/A
11/21/2024
8:15 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:15 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:15 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
8:25 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:29 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Toh Kean Meng Melvin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2024
3:30 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Yu Ying Choi Alan Abel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2024
3:29 PM
CK Life Sciences Intl Inc (0001297567) (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Sealbond Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2024
3:19 PM
Sealbond Ltd (Filed by)
Virios Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Form SC 13D
10/07/2024
7:06 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form DEFA14A
10/07/2024
7:02 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
08/09/2024
9:15 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
8:30 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DWTX) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners